Hypoglycemia

Canadian Journal of Diabetes

Volumn 37, Issue SUPPL.1, 2013, Pages

  Clayton, Dale ^a   Woo, Vincent ^a   Yale, Jean François ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCAGON; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; INSULIN;

AGE; ARTICLE; AUTONOMIC NEUROPATHY; BRAIN DYSFUNCTION; CHRONIC DISEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRIVING ABILITY; FOOD INSECURITY; HEALTH STATUS; HEMIPARESIS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTELLECTUAL IMPAIRMENT; KIDNEY DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; TRAFFIC ACCIDENT; TREATMENT DURATION; CANADA; CHEMICALLY INDUCED; DIABETES MELLITUS; PRACTICE GUIDELINE; RISK FACTOR;

CANADA; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; RISK FACTORS;

EID: 84876060197     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.01.022     Document Type: Article

References (45)

1. Alvarez-Guisasola F., Yin D.D., Nocea G., et al. Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: A cross sectional study. Health Qual Life Outcomes 2010, 8:86.
2. Anderbro T., Amsberg S., Adamson U., et al. Fear of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2010, 27:1151-1158.
3. Belendez M., Hernandez-Mijares A. Beliefs about insulin as a predictor of fear of hypoglycaemia. Chronic Illn 2009, 5:250-256.
4. Barnard K., Thomas S., Royle P., et al. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr 2010, 10:50.
5. Di Battista A.M., Hart T.A., Greco L., Gloizer J. Type 1 diabetes among adolescents: reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ 2009, 35:465-475.
6. Haugstvedt A., Wentzel-Larsen T., Graue M., et al. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 2010, 27:72-78.
7. Hepburn D.A. Symptoms of hypoglycaemia. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects 1993, 93-103. Edward Arnold, London, UK. B.M. Frier, B.M. Fisher (Eds.).
8. Davis S.N., Mann S., Briscoe V.J., et al. Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes 2009, 58:701-709.
9. Tsalikian E., Tamborlane W., Xing D., et al. Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care 2009, 32:1954-1959. Diabetes Research in Children Network (DirecNet) Study Group.
10. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996, 124:379-388. The Diabetes Control and Complications Trial Research Group.
11. Reichard P., Pihl M. Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 1994, 43:313-317.
12. Jacobson A.M., Musen G., Ryan C.M., et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007, 356:1842-1852. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Published erratum appears in N Engl J Med. 2009;361:1914.
13. Brands A.M., Biessels G.J., de Haan E.H., et al. The effects of type1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005, 28:726-735.
14. Whitmer R.A., Karter A.J., Yaffe K., et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301(15):1565-1572.
15. Bonds D.E., Miller M.E., Bergenstal R.M., et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010, 340:b4909.
16. Wright R.J., Newby D.E., Stirling D., et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 2010, 33:1591-1597.
17. Koivikko M.L., Karsikas M., Salmela P.I., et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia 2008, 51:426-435.
18. Kubiak T., Wittig A., Koll C., et al. Continuous glucose monitoring reveals associations of glucose levels with QT interval length. Diabetes Technol Ther 2010, 12:283-286.
19. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 1995, 18:1415-1427. The Diabetes Control and Complications Trial Research Group.
20. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997, 46:271-286. The Diabetes Control and Complications Trial Research Group.
21. Mühlhauser I., Overmann H., Bender R., et al. Risk factors of severe hypoglycaemia in adult patients with type I diabetes: a prospective population based study. Diabetologia 1998, 41:1274-1282.
22. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991, 90:450-459. The DCCT Research Group.
23. Davis E.A., Keating B., Byrne G.C., et al. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997, 20:22-25.
24. Egger M., Davey Smith G., Stettler C., et al. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997, 14:919-928.
25. Gold A.E., MacLeod K.M., Frier B.M. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994, 17:697-703.
26. Mokan M., Mitrakou A., Veneman T., et al. Hypoglycemia unawareness in IDDM. Diabetes Care 1994, 17:1397-1403.
27. Meyer C., Grossmann R., Mitrakou A., et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care 1998, 21:1960-1966.
28. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994, 125:177-188. Diabetes Control and Complications Trial Research Group.
29. Miller M.E., Bonds D.E., Gerstein H.C., et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010, 340:b5444.
30. de Galan B.E., Zoungas S., Chalmers J., et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009, 52:2328-2336.
31. Sarkar U., Karter A.J., Liu J.Y., et al. Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med 2010, 25:962-968. Published erratum appears in J Gen Intern Med. 2010;25:1258.
32. Seligman H.K., Davis T.C., Schillinger D., Wolf M.S. Food insecurity is associated with hypoglycemia and poor diabetes self-management in a low-income sample with diabetes. J Health Care Poor Underserved 2010, 21:1227-1233.
33. Davis T.M., Brown S.G., Jacobs I.G., et al. Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. J Clin Endocrinol Metab 2010, 95:2240-2247.
34. Schopman J.E., Geddes J., Frier B.M. Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes. Diabetes Res Clin Pract 2010, 87:64-68.
35. Slama G., Traynard P.Y., Desplanque N., et al. The search for an optimized treatment of hypoglycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 1990, 150:589-593.
36. Wiethop B.V., Cryer P.E. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993, 16:1131-1136.
37. Brodows R.G., Williams C., Amatruda J.M. Treatment of insulin reactions in diabetics. JAMA 1984, 252:3378-3381.
38. Special problems. Medical Management of Type 1 Diabetes 1998, 134-143. American Diabetes Association, Alexandria, VA. 3rd ed. J.S. Skyler (Ed.).
39. The role of dietary sugars in diabetes mellitus. Beta Release 1991, 15:117-123. Canadian Diabetes Association.
40. Gunning R.R., Garber A.J. Bioactivity of instant glucose. Failure of absorption through oral mucosa. JAMA 1978, 240:1611-1612.
41. ® (acarbose) [product monograph] 2007, Bayer Inc., Toronto, ON.
42. Cryer P.E., Fisher J.N., Shamoon H. Hypoglycemia. Diabetes Care 1994, 17:734-755.
43. Glucagon [product monograph] 2007, Eli Lilly Canada Inc., Toronto, ON.
44. ® (glucagon) [product monograph] 2002, Novo Nordisk, Bagsvaerd, Denmark.
45. Kagan A., Hashemi G., Korner-Bitensky N. Diabetes and fitness to drive: a systematic review of the evidence with a focus on older drivers. Canadian J Diabetes 2010, 34:233-242.